The submissions are for generic forms of semaglutide, the active ingredient in Novo Nordisks injectable drugs Ozempic and Wegovy, the former approved by Health Canada for diabetes and the latter for weight loss
People interested in how peptides can support the post-GLP-1 phase can review peptides for fat loss and the broader peptides for weight loss guide for strategies that support the transition
Beyond appetite control, it boosts calorie-burning by stimulating insulin release helping your body use stored fat for energy
All of them have similar side effects, the most common being nausea, diarrhea, vomiting, and constipation
When taking GLP-1 medications like Ozempic, protein becomes more important because appetite and overall food intake are lower
Youll receive a secure video link by email